Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis delivers promising Ph3 data for combo COPD treatment
Fierce Biotech
Monday, May 16, 2011 - 11:43am
tags:
Novartis, COPD, Onbrez Breezhaler
Analysis: Big Pharma is backing out of more biotech deals
Fierce Biotech
Monday, May 16, 2011 - 11:41am
tags:
biotech, Big Pharma
Shanghai Pharma IPO yields $2B
Fierce Pharma
Monday, May 16, 2011 - 11:21am
tags:
Shanghai Pharmaceutical, IPOs, Hong Kong
Mylan launches generic version of Xibrom eye drops
Yahoo/AP
Monday, May 16, 2011 - 11:19am
tags:
Xibrom, generics, Mylan, cataracts, Ista
Why Synergy Pharmaceuticals Could Go From $4 to $40
Seeking Alpha
Monday, May 16, 2011 - 11:18am
tags:
SYNERGY
Lilly Rejected by U.S. Supreme Court in Gemzar Patent Case
Bloomberg
Monday, May 16, 2011 - 11:14am
tags:
patents, Supreme Court, Gemzar, Eli Lilly, Teva Pharmaceuticals, Hospira, cancer
Exelixis: Looming Cancer Conference a Favorable Swing Trade Opportunity
Seeking Alpha
Monday, May 16, 2011 - 9:33am
tags:
Exelixis, cancer, tyrosine kinases
Amylin Pharma sues Eli Lilly over diabetes drug development deal with Boehringer Ingelheim
Yahoo/AP
Monday, May 16, 2011 - 9:32am
tags:
Amylin, lawsuits, Eli Lilly, Boehringer Ingelheim, diabetes, Byetta
Elan move makes it a sitting duck for big boys
Independent, Ireland
Monday, May 16, 2011 - 9:30am
tags:
Elan, M&A, Alkermes, JNJ
The Merck Hepatitis C Med: What The Wags Say
Pharmalot
Monday, May 16, 2011 - 9:29am
tags:
Merck, hepatitis C, Boceprevir, Vertex Pharmaceuticals, Telaprevir
Teva Pharma buys majority stake in Taiyo for $460M
Yahoo/AP
Monday, May 16, 2011 - 9:27am
tags:
Teva Pharmaceuticals, Taiyo, M&A, Japan
Glenmark Sells Rights to New Drug to Sanofi
WSJ Online
Monday, May 16, 2011 - 9:21am
tags:
Glenmark, Sanofi, Crohn's Disease, GBR500
China Biotech Week in Review: Deals and Transactions, SFDA Approvals
Seeking Alpha
Monday, May 16, 2011 - 9:20am
tags:
China, Chongqing Zhifei Biological, Sinopharm, Sanofi, Simcere, WuXi PharmaTech, Tianyin Pharmaceutical
Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society
PR-USA.net
Saturday, May 14, 2011 - 1:48pm
tags:
Amira, AM152, fibrosis
GSK, University of Manchester & AstraZeneca create Manchester Collaborative Centre for Inflammation Research
pharmabiz
Saturday, May 14, 2011 - 1:45pm
tags:
GSK, AstraZeneca
SuperGen finds its way
Contra Costa Times, CA
Saturday, May 14, 2011 - 1:07pm
tags:
Supergen
My visit to Nimbus, Bill Gates' bet on virtual drug discovery
Fierce Biotech IT
Saturday, May 14, 2011 - 1:05pm
tags:
Nimbus Discovery
Pfizer CME effort lacks brand tie-in
Medical Marketing & Media
Saturday, May 14, 2011 - 1:03pm
tags:
Pfizer, marketing, CME
The Next Big Thing In Biotech: Abbott Labs (video)
The Street
Saturday, May 14, 2011 - 12:56pm
tags:
Abbott Laboratories
Merck Wins FDA Backing for Hepatitis C Drug
Bloomberg
Saturday, May 14, 2011 - 12:54pm
tags:
Merck, hepatitis C, Victrelis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.